Long-term outcome of 'super-responder' patients to cardiac resynchronization therapy

Europace

Volumn 16, Issue 3, 2014, Pages 363-371

  Zecchin, Massimo ^a   Proclemer, Alberto ^a   Magnani, Silvia ^a   Vitali Serdoz, Laura ^a   Facchin, Domenico ^b   Muser, Daniele ^b   Nordio, Andrea ^a   Barbati, Giulia ^a   Puggia, Ilaria ^a   Sinagra, Gianfranco ^a   Proclemer, Alessandro ^b  

^a UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cardiac resynchronization therapy; Heart failure; Outcome; Super responders

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE EJECTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SUDDEN DEATH; TREATMENT OUTCOME;

CARDIAC RESYNCHRONIZATION THERAPY; HEART FAILURE; OUTCOME; SUPER-RESPONDERS;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84895744320     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut339     Document Type: Article

References (32)

1. Daubert JC, Saxon L, Adamson PB, Auricchio A, Berger RD, Beshai JF et al. EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 2012; 14:1236-86.
2. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) Europace 2013;15:1070-118.
3. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD et al. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 2010;121:1985-91.
4. Castellant P, Orhan E, Bertault-Valls V, Fatemi M, Etienne Y, Blanc J-J. Is 'hyper response' to cardiac resynchronization therapy in patients with nonischemic cardiomyopathy a recovery, a remission, or a control? Ann Noninvasive Electrocardiol 2010;15:321-7.
5. Blanc JJ, Fatemi M, Bertault V, Baraket F, Etienne Y. Evaluation of left bundle branch block as a reversible cause of non-ischaemic dilated cardiomyopathy with severe heart failure. A new concept of left ventricular dyssynchrony-induced cardiomyopathy. Europace 2005;7:604-10.
6. Vaillant C, Martins RP, Donal E, Leclercq C, Thébault C, Behar N, et al. Resolution of left bundle branch block-induced cardiomyopathy by cardiac resynchronization therapy. J Am Coll Cardiol 2013;61:1089-95.
7. Ellenbogen KA, Huizar JF. Foreseeing super-response to cardiac resynchronization therapy: a perspective for clinicians. J Am Coll Cardiol 2012;59:2374-7.
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Lang Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
9. Pinamonti B, Zecchin M, Di Lenarda A, Gregori D, Sinagra G, Camerini F. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol 1997;29:604-12.
10. Spain MG, Smith MD, Grayburn PA, Harlamert EA, DeMaria AN. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J Am Coll Cardiol 1989;13:585-90.
11. Harrell FE. Overfitting and limits on numbers of predictors. In Harrell FE eds. Regression Modeling Strategies. Springer-Verlag: New York; 2001. p.61.
12. Ghio S, Freemantle N, Scelsi L, Serio A, Magrini G, Pasotti M, et al. Long-term left ventricular reverse remodeling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail 2009;11:480-8.
13. Linde C, Gold MR, Abraham WT, Sutton MSJ, Ghio S, Cerkvenik J et al. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study Eur Heart J 2013;34:2592-9.
14. Serdoz LV, Daleffe E, Merlo M, Zecchin M, Barbati G, Pecora D et al. Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation. Am J Cardiol 2011;108:75-80.
15. Mascioli G, Padeletti L, Sassone B, Zecchin M, Lucca E, Sacchi S et al. Electrocardiographic criteria of true left bundle branch block: a simple sign to predict a better clinical and instrumental response to CRT. PACE 2012;35:927-34.
16. Bertini M, Höke U, van Bommel RJ, Ng AC, Shanks M, Nucifora G, et al. Impact of clinical and echocardiographic response to cardiac resynchronization therapy on longterm survival. Eur Heart J Cardiovasc Imaging 2012;14:774-81.
17. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009;53:483-9.
18. Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H et al. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) Study. J Am Coll Cardiol 2012;59:2366-73.
19. Castellant P, Fatemi M, Orhan E, Etienne Y, Blanc JJ. Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution. Europace 2009;11:350-5.
20. Manne M, Rickard J, Varma N, Chung Mk, Tchou P. Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival. Pacing Clin Electrophysiol. 2013;36:970-7.
21. Barsheshet A, Wang PJ, Moss AJ, Solomon SD, Al-Ahmad A, McNitt S et al. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011;58:548-9.
22. Gold MR, Linde C, Abraham WT, Gardiwal A, Daubert JC. The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure. Heart Rhythm 2011;5:679-84.
23. Aiba T, Tomaselli GF. Electrical remodeling in the failing heart. Curr Opin Cardiol 2010; 25:29-36.
24. Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, et al.ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy. Heart Rhythm 2013;10:1547-71.
25. Van Boven N, Bogaard K, Ruiter J, Kimman G, Theuns D, Kardys I et al. Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks. J Cardiovasc Electrophysiol 2013;24: 316-22.
26. Mann DL, Barger PM, Burkhoff D. Myocardial recovery and the failing heart: myth, magic or molecular target? J Am Coll Cardiol 2012;60:2465-72.
27. Aiba T, Hesketh GG, Barth AS, Liu T, Daya S, Chakir K et al. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 2009;119:1220-30.
28. Merlo M, Pyxaras SA, Pinamonti B, Barbati G, Di Lenarda A, Sinagra G. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 2011;57: 1468-76.
29. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E et al.; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006;113:776-82.
30. Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R et al. Limitations of the New York Heart Association functional classification system and selfreported walking distances in chronic heart failure. Heart 2007;93:476-82.
31. Stefan L, Sedlacek K, Cerna D, Kryze L, Vancura V, Marek T, et al. Small left atrium and mild mitral regurgitation predict super-response to cardiac resynchronization therapy. Europace 2012;14:1608-14.
32. Breithardt G. MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure. Eur Heart J 2009;30:2551-3.